SCHEMBL28839286

SCHEMBL28839286

Fc1ccc2c(ccn2C2CC2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.48
HTR7 P34969 2/20 0.48
KCNH2 Q12809 1/20 0.48
TFPI2 P48307 1/20 0.42
HTR2C P28335 1/20 0.41
SCD O00767 7/20 0.40
HTR1A P08908 1/20 0.40
HTR1D P28221 1/20 0.40
HTR1B P28222 1/20 0.40
HTR1F P30939 1/20 0.40
OPRM1 P35372 1/20 0.39
OPRD1 P41143 1/20 0.39
OPRK1 P41145 1/20 0.39
OPRL1 P41146 1/20 0.39
DRD2 P14416 1/20 0.39
SLC6A4 P31645 1/20 0.39
CYP11B1 P15538 3/20 0.38
CYP11B2 P19099 3/20 0.38
PRKAG1 P54619 1/20 0.37
PRKAA1 Q13131 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7149460 0.89 CCR3 (0.46) HTR2AHTR7KCNH2TFPI2HTR2C
SCHEMBL6589098 0.87 HTR1A (0.54) HTR2AHTR7KCNH2SCDHTR1A
SCHEMBL31434301 0.83 HTR2A (0.45) HTR2AHTR7KCNH2TFPI2HTR2C
SCHEMBL21525109 0.80 HTR2A (0.43) HTR2AHTR7KCNH2TFPI2HTR2C
SCHEMBL24109849 0.79 HTR2A (0.43) HTR2AHTR7KCNH2TFPI2HTR2C
SCHEMBL31196415 0.79 HTR2A (0.40) HTR2AHTR7KCNH2TFPI2HTR2C
SCHEMBL15520260 0.78 SCD (0.49) HTR2AHTR7KCNH2HTR2CSCD
SCHEMBL31196468 0.78 TFPI2 (0.46) HTR2AHTR7KCNH2TFPI2HTR2C
SCHEMBL31196274 0.78 TFPI2 (0.46) HTR2AHTR7KCNH2TFPI2HTR2C
SCHEMBL31196245 0.78 TFPI2 (0.46) HTR2AHTR7KCNH2TFPI2HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115073426-A Pyrimidine heterocyclic compound and preparation method and application thereof 上海科州药物研发有限公司 2022-09-20 CN disclosed